JPMORGAN CHASE & CO - PMV PHARMACEUTICALS INC ownership

PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 109 filers reported holding PMV PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of PMV PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$24,767,046
-2.9%
4,033,721
-1.0%
0.00%0.0%
Q2 2023$25,512,656
+33.6%
4,075,504
+1.8%
0.00%
+50.0%
Q1 2023$19,094,000
+53474.6%
4,002,884
-2.3%
0.00%
-60.0%
Q4 2022$35,640
-99.9%
4,096,551
-13.0%
0.01%
-37.5%
Q3 2022$56,003,000
-20.1%
4,706,099
-4.3%
0.01%
-20.0%
Q2 2022$70,100,000
+5.0%
4,919,323
+53.5%
0.01%
+25.0%
Q1 2022$66,739,000
-8.8%
3,205,487
+1.2%
0.01%0.0%
Q4 2021$73,164,000
+35.9%
3,167,222
+75.3%
0.01%
+14.3%
Q3 2021$53,852,000
-4.1%
1,807,092
+10.0%
0.01%0.0%
Q2 2021$56,127,000
+82.4%
1,643,064
+75.7%
0.01%
+75.0%
Q1 2021$30,765,000
+1248.2%
935,390
+2421.3%
0.00%
Q4 2020$2,282,000
+500.5%
37,099
+271.0%
0.00%
Q3 2020$380,00010,0000.00%
Other shareholders
PMV PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 1,614,911$19,217,00059.24%
Euclidean Capital LLC 2,336,909$27,809,00025.82%
OUP Management Co., LLC 989,232$11,772,00018.33%
Nextech Invest Ltd. 1,385,807$16,491,0005.33%
Boxer Capital, LLC 3,163,795$37,649,0002.12%
PERSONAL CFO SOLUTIONS, LLC 550,342$6,549,0001.64%
Orbimed Advisors 6,563,077$78,101,0001.45%
RTW INVESTMENTS, LP 4,356,920$51,847,0001.20%
ACUTA CAPITAL PARTNERS, LLC 154,500$1,839,0000.79%
Monarch Partners Asset Management LLC 210,370$2,503,0000.75%
View complete list of PMV PHARMACEUTICALS INC shareholders